Welcome on the website of the European Network for the Cure of ALS (ENCALS), formally named EALSC

The aims of ENCALS are:

1. To develop an European ALS trial network + database/biobank that
   • is recognized, visible, active and efficient;
   • agrees on collection/storage of clinical data and biospecimens on a European level;
   • agrees on trial designs for phase II and phase III trials;
   • will attract pharmaceutical companies to conduct trials in ALS in Europe;
   • will be able to conduct efficiently (web-based) multinational trials within reasonable time periods;
   • facilitates associated patient-oriented research projects (phenotyping, epidemiology, biomarkers, etc).
2. To initiate collaboration between funding agencies in Europe to sponsor collectively investigator-initiated European trials in ALS.
3. To reach consensus on a classification of ALS suitable for use in randomized clinical trials.
4. To study novel designs for the assessment of the efficacy of new pharmaceutical compounds in ALS.